ASRT vs RUN · rev $125.0M vs P/E 6.0, rev $2.04B
Assertio Therapeutics Inc (ASRT) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
ASRT currently screens at market cap $151.5M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the ASRT and RUN stock pages for the full models.
Not investment advice.